Cash and Cash Equivalents, at Carrying Value of Tevogen Bio Holdings Inc. from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit: us-gaap: USD
Description: Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.
Summary: Tevogen Bio Holdings Inc. quarterly Cash and Cash Equivalents, at Carrying Value in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
Tevogen Bio Holdings Inc. Cash and Cash Equivalents, at Carrying Value for the quarter ending 31 Dec 2024 was $0.
Source SEC data: View on sec.gov

Cash and Cash Equivalents, at Carrying Value, Quarterly (USD)

Cash and Cash Equivalents, at Carrying Value, YoY Quarterly Change (%)

Tevogen Bio Holdings Inc. Quarterly Cash and Cash Equivalents, at Carrying Value (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2024	$0	$0		31 Dec 2024	10-K	02 Apr 2025	2024	FY
Q4 2023	$0	-$129,186	-100%	31 Dec 2023	10-K	02 Apr 2025	2024	FY
Q3 2023	$25,000,000	+$24,856,953	+17377%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$25,000,000	+$24,814,355	+13367%	30 Jun 2023	10-Q	21 Aug 2023	2023	Q2
Q4 2022	$129,186	-$215,395	-63%	31 Dec 2022	10-K	17 Apr 2023	2022	FY
Q3 2022	$143,047			30 Sep 2022	10-Q	14 Nov 2022	2022	Q3
Q2 2022	$185,645			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$231,546			31 Mar 2022	10-Q	17 May 2022	2022	Q1
Q4 2021	$344,581			31 Dec 2021	10-K	17 Apr 2023	2022	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.